The pharmacokinetics of PegIntron following a single subcutaneous dose of 1.0 microgram/kg were not affected by age.
Nahaalusi manustatud ühekordse PegIntron’ i annuse 1, 0 μg/ kg farmakokineetikat vanus ei mõjutanud.